Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Share Price

Price 14,210.00p on 12-01-2026 at 09:30:23
Change -6.00p -0.04%
Buy 14,212.00p
Sell 14,208.00p
Add to Watchlist
Add to Portfolio
Add to Quickpicks
Last Trade: Sell 70.00 at 14,210.00p
Day's Volume: 95,299
Last Close: 14,216.00p
Open: 14,036.00p
ISIN: GB0009895292
Day's Range 13,988.00p - 14,228.00p
52wk Range: 9,574.00p - 14,330.00p
Market Capitalisation: £220.30b
VWAP: 14,105.67401p
Shares in Issue: 1.55b

Sector: Medicine and Biotech

Listed In: FTSE All-Share, FTSE All-Share ex Investment Trusts, FTSE Lower Yield, FTSE 350 ex Investment Trusts, FTSE 350 , FTSE 100,

Astrazeneca (AZN) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 70 14,210.00p Automatic Execution
 09:30:22 - 12-Jan-26
Buy* 74 14,210.00p Automatic Execution
 09:30:22 - 12-Jan-26
Unknown* 0 14,214.00p SI Trade
 09:29:55 - 12-Jan-26
Unknown* 0 14,214.00p SI Trade
 09:29:53 - 12-Jan-26
Buy* 33 14,214.00p Automatic Execution
 09:29:50 - 12-Jan-26
Buy* 48 14,212.00p Automatic Execution
 09:29:49 - 12-Jan-26
Buy* 25 14,212.00p Automatic Execution
 09:29:49 - 12-Jan-26
Sell* 6 14,212.00p Automatic Execution
 09:29:42 - 12-Jan-26
Sell* 34 14,212.00p Automatic Execution
 09:29:42 - 12-Jan-26
Buy* 14 14,215.28p Ordinary
 09:29:33 - 12-Jan-26
See more Astrazeneca trades

Astrazeneca (AZN) Share Price History

Time period:
to
Date Open High Low Close Volume
12th Jan 2026 (Mon) 14,036.00 14,228.00 13,988.00 14,216.00 95,299
9th Jan 2026 (Fri) 14,010.00 14,330.00 13,974.00 14,216.00 1,510,712
8th Jan 2026 (Thu) 14,030.00 14,292.00 14,022.00 14,176.00 2,489,065
7th Jan 2026 (Wed) 14,050.00 14,312.00 14,038.00 14,224.00 2,010,791
6th Jan 2026 (Tue) 13,400.00 14,114.00 13,392.00 14,038.00 2,053,602
5th Jan 2026 (Mon) 13,644.00 13,644.00 13,278.00 13,384.00 1,631,479
2nd Jan 2026 (Fri) 13,722.00 13,916.00 13,592.00 13,592.00 3,980,211
1st Jan 2026 (Thu) 13,790.00 13,790.00 13,790.00 13,790.00 0
31st Dec 2025 (Wed) 13,768.00 13,844.00 13,722.00 13,790.00 393,700
30th Dec 2025 (Tue) 13,712.00 13,798.00 13,696.00 13,750.00 950,185
29th Dec 2025 (Mon) 13,736.00 13,806.00 13,680.00 13,748.00 1,490,186
26th Dec 2025 (Fri) 13,674.00 13,674.00 13,674.00 13,674.00 0
25th Dec 2025 (Thu) 13,674.00 13,674.00 13,674.00 13,674.00 0
24th Dec 2025 (Wed) 13,742.00 13,742.00 13,612.00 13,674.00 688,169
23rd Dec 2025 (Tue) 13,612.00 13,806.00 13,604.00 13,736.00 1,082,889
22nd Dec 2025 (Mon) 13,592.00 13,632.00 13,476.00 13,632.00 1,451,074
19th Dec 2025 (Fri) 13,574.00 13,714.00 13,508.00 13,672.00 10,404,455
18th Dec 2025 (Thu) 13,500.00 13,594.00 13,376.00 13,548.00 4,515,814
17th Dec 2025 (Wed) 13,574.00 13,682.00 13,534.00 13,554.00 2,468,738
16th Dec 2025 (Tue) 13,744.00 13,836.00 13,448.00 13,506.00 3,264,005
15th Dec 2025 (Mon) 13,412.00 13,638.00 13,376.00 13,612.00 2,467,612
12th Dec 2025 (Fri) 13,502.00 13,536.00 13,362.00 13,444.00 1,443,553
See more Astrazeneca price history

Astrazeneca (AZN) Regulatory News

Date Source Headline
8th Jan 2026 7:00 am RNS AZN new Head of Investor Relations Joris Silon
2nd Jan 2026 3:00 pm RNS Total Voting Rights
22nd Dec 2025 11:00 am RNS Director/PDMR Shareholding
22nd Dec 2025 11:00 am RNS Director/PDMR Shareholding
22nd Dec 2025 7:30 am RNS Enhertu granted BTD for post-neoadjuvant early BC
22nd Dec 2025 7:30 am RNS Enhertu granted BTD for post-neoadjuvant early BC
22nd Dec 2025 7:00 am RNS Update on LATIFY Phase III trial of ceralasertib
22nd Dec 2025 7:00 am RNS Update on LATIFY Phase III trial of ceralasertib
19th Dec 2025 11:00 am RNS Director/PDMR Shareholding
19th Dec 2025 11:00 am RNS Director/PDMR Shareholding
See more Astrazeneca regulatory news

Astrazeneca (AZN) Share News

LONDON BROKER RATINGS: Berenberg raises Vodafone; Barclays cuts Hikma

7th Jan 2026 10:04

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday: Read More

LONDON MARKET CLOSE: Next impresses as FTSE 100 rockets to fresh high

6th Jan 2026 17:04

(Alliance News) - Blue chips continued their strong start to the year on Tuesday with the FTSE 100 hitting a new record led by gains in retailer Next and drug stocks, GSK and AstraZeneca. Read More

AstraZeneca flags positive trial data for Saphnelo as SLE treatment

6th Jan 2026 09:47

(Alliance News) - AstraZeneca PLC on Tuesday said a Saphnelo self-administration Thlip-SC trial demonstrated statistically significant and clinically meaningful reduction in systemic lupus erythematosus disease activity. Read More

Hutchmed savolitinib NDA for gastric cancer accepted in China

30th Dec 2025 11:21

(Alliance News) - Hutchmed China Ltd on Tuesday said Chinese regulators have accepted and granted priority review to its new drug application for savolitinib to treat certain patients with advanced gastric cancer, marking another regulatory step forward for the targeted therapy. Read More

LONDON MARKET CLOSE: FTSE fails to sparkle in tame pre-holiday trade

24th Dec 2025 13:14

(Alliance News) - The FTSE 100 drifted lower on Wednesday in lacklustre trading ahead of the Christmas break, although a chunky disposal by BP brought some life to proceedings. Read More

See more Astrazeneca news
FTSE 100 Latest
Value10,124.31
Change-0.29

Login to your account

Forgot Password?

Not Registered